Why Participation in Brain Tumor Clinical Trials Remains Challenging for Patients – WeTrials
WeTrials/X

Why Participation in Brain Tumor Clinical Trials Remains Challenging for Patients – WeTrials

WeTrials shared a post on LinkedIn:

“Clinical trials shape the future of brain tumor treatment — but accessing them shouldn’t feel impossible.

Dr. Alireza Mansouri explains why trial participation is so challenging for patients and what democratizing access really means:

  • Simpler information
  • Better education
  • Real support in decision-making

Understanding your options is the first step toward feeling confident in your care decisions.

Explore patient-friendly care resources.”

Proceed to the video attached to the post.

More posts about brain tumor.